Free Trial

NexImmune (NEXI) SEC Filings & 10K Form

NexImmune logo
$0.24 +0.00 (+1.21%)
(As of 01:36 PM ET)

Recent NexImmune SEC Filings

DateFilerForm TypeView
09/06/2024
6:41 AM
Nasdaq Stock Market LLC (Filed by)
NexImmune (Subject)
Form 25-NSE
08/28/2024
11:15 PM
NexImmune (Filer)
Form EFFECT
08/27/2024
3:10 PM
NexImmune (Filer)
Form S-8 POS
08/27/2024
3:01 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
3:03 PM
NexImmune (Filer)
Form POS AM
08/27/2024
3:06 PM
NexImmune (Filer)
Form S-8 POS
08/27/2024
3:08 PM
NexImmune (Filer)
Form S-8 POS
07/19/2024
3:01 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:03 PM
NexImmune (Filer)
Form DEFA14A
07/11/2024
2:10 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
2:12 PM
NexImmune (Filer)
Form DEFA14A
06/21/2024
6:30 AM
NexImmune (Filer)
Form DEF 14A
06/13/2024
6:58 PM
Jones Kristi (Reporting)
NexImmune (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
4:17 PM
NexImmune (Filer)
Form PRE 14A
05/20/2024
4:10 PM
NexImmune (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2024
4:13 PM
Marchio Albert N II (Reporting)
NexImmune (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/06/2024
3:30 PM
NexImmune (Filer)
Form DEFA14A
02/05/2024
4:10 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2024
3:34 PM
NexImmune (Filer)
Form 424B5
02/02/2024
12:25 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
8:17 AM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:43 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
3:43 PM
NexImmune (Filer)
Form DEFA14A
12/22/2023
3:01 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
12:39 PM
NexImmune (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
4:40 PM
NexImmune (Subject)
Roemer Alan S. (Reporting)
Form 144/A
11/22/2023
4:34 PM
NexImmune (Subject)
Roemer Alan S. (Reporting)
Form 144/A
11/22/2023
4:18 PM
NexImmune (Issuer)
Roemer Alan S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:39 PM
NexImmune (Subject)
Roemer Alan S. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/20/2023
4:19 PM
NexImmune (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NEXI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners